Handelsbanken Fonder’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-26,000
| Closed | -$178K | – | 1583 |
|
|
2023
Q1 | $178K | Hold |
26,000
| – | – | ﹤0.01% | 1472 |
|
|
2022
Q4 | $206K | Buy |
26,000
+7,200
| +38% | +$57K | ﹤0.01% | 1426 |
|
|
2022
Q3 | $181K | Hold |
18,800
| – | – | ﹤0.01% | 1453 |
|
|
2022
Q2 | $136K | Hold |
18,800
| – | – | ﹤0.01% | 1551 |
|
|
2022
Q1 | $243K | Hold |
18,800
| – | – | ﹤0.01% | 1588 |
|
|
2021
Q4 | $300K | Hold |
18,800
| – | – | ﹤0.01% | 1614 |
|
|
2021
Q3 | $302K | Hold |
18,800
| – | – | ﹤0.01% | 1588 |
|
|
2021
Q2 | $260K | Buy |
18,800
+8,600
| +84% | +$119K | ﹤0.01% | 1665 |
|
|
2021
Q1 | $149K | Hold |
10,200
| – | – | ﹤0.01% | 1552 |
|
|
2020
Q4 | $177K | Hold |
10,200
| – | – | ﹤0.01% | 1528 |
|
|
2020
Q3 | $187K | Hold |
10,200
| – | – | ﹤0.01% | 1397 |
|
|
2020
Q2 | $182K | Buy |
+10,200
| New | +$182K | ﹤0.01% | 1391 |
|
|
2017
Q4 | – | Sell |
-70,000
| Closed | -$934K | – | 195 |
|
|
2017
Q3 | $934K | Buy |
70,000
+15,000
| +27% | +$200K | 0.02% | 167 |
|
|
2017
Q2 | $789K | Buy |
55,000
+10,000
| +22% | +$143K | 0.02% | 161 |
|
|
2017
Q1 | $952K | Hold |
45,000
| – | – | 0.03% | 159 |
|
|
2016
Q4 | $1.27M | Hold |
45,000
| – | – | 0.04% | 141 |
|
|
2016
Q3 | $1.21M | Hold |
45,000
| – | – | 0.04% | 143 |
|
|
2016
Q2 | $760K | Sell |
45,000
-10,000
| -18% | -$169K | 0.03% | 136 |
|
|
2016
Q1 | $1.17M | Sell |
55,000
-100,000
| -65% | -$2.12M | 0.05% | 124 |
|
|
2015
Q4 | $3.56M | Buy |
+155,000
| New | +$3.56M | 0.07% | 237 |
|